Krystal Biotech
KRYS
KRYS
188 hedge funds and large institutions have $2.76B invested in Krystal Biotech in 2023 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 89 increasing their positions, 52 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
2% more capital invested
Capital invested by funds: $2.71B → $2.76B (+$54.6M)
4.34% less ownership
Funds ownership: 89.36% → 85.02% (-4.3%)
42% less call options, than puts
Call options by funds: $22.5M | Put options by funds: $38.5M
Holders
188
Holding in Top 10
8
Calls
$22.5M
Puts
$38.5M
Top Buyers
| 1 | +$80.5M | |
| 2 | +$32.8M | |
| 3 | +$32.2M | |
| 4 |
FAM
Fred Alger Management
New York
|
+$19M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$16.1M |
Top Sellers
| 1 | -$65.3M | |
| 2 | -$41.1M | |
| 3 | -$27.1M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$19.9M |
| 5 |
B
Braidwell
Stamford,
Connecticut
|
-$19M |